| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/22/2004 | US20040014735 11-Beta substituted 19-nor-17-alpha-pregna-1,3,5(10)-trien-17beta-ols with a 21,16alpha-lactone ring |
| 01/22/2004 | US20040014734 Anticholesterol agents |
| 01/22/2004 | US20040014733 Anticholesterol agents; mixture with emulsifier; bioavailability |
| 01/22/2004 | US20040014732 A topical antiandrogen for hair loss and other hyperandrogenic conditions |
| 01/22/2004 | US20040014731 Use of non-antibacterial tetracycline analogs and formulations thereof for the treatment of bacterial exotoxins |
| 01/22/2004 | US20040014730 Side effect reduction of microbiocides, viricides, fungicides |
| 01/22/2004 | US20040014729 Bone disorders; anticancer agents |
| 01/22/2004 | US20040014728 Compositions for treating diabetes |
| 01/22/2004 | US20040014727 Stimulant bone proliferation |
| 01/22/2004 | US20040014726 Method for the preparation of a pharmaceutical composition, and its use |
| 01/22/2004 | US20040014725 Adjust diffusion of oxygen; respiratory system disorders; cardiovascular disorders |
| 01/22/2004 | US20040014724 Method of administering a bisphosphonate |
| 01/22/2004 | US20040014723 Calcilytic compounds |
| 01/22/2004 | US20040014722 Viricides |
| 01/22/2004 | US20040014721 Method for using tethered bis(polyhydroxyphenyls) and O-alkyl derivatives thereof in treating inflammatory conditions of the central nervous system |
| 01/22/2004 | US20040014720 Hypotensive agents |
| 01/22/2004 | US20040014719 Method of promoting angiogenesis |
| 01/22/2004 | US20040014718 Clear aqueous anaesthetic composition |
| 01/22/2004 | US20040014715 Use of beta-glucans against biological warfare weapons and pathogens including anthrax |
| 01/22/2004 | US20040014712 Blood lipid ameliorant composition |
| 01/22/2004 | US20040014711 Cytidine diphosphate choline ester |
| 01/22/2004 | US20040014710 Methods for modulating the axonal outgrowth of central nervous system neurons |
| 01/22/2004 | US20040014706 Using protein antagonist; therapy for congestive heart failure; blocking gene expression |
| 01/22/2004 | US20040014700 Novel oligonucleotides and use of oligonucleotides modulating the expression of enzymes involved in the synthesis of melanic pigments, as depigmentation agents |
| 01/22/2004 | US20040014696 Using blocking agent which is removal with enzyme |
| 01/22/2004 | US20040014694 Therapy for breast cancer |
| 01/22/2004 | US20040014693 Use of arginine in the preparation of a medicament for the prevention and treatment of the side effects associated with the intravenous administration of pharmaceuticals |
| 01/22/2004 | US20040014692 Controlling concentration of cholesterol, leptin and serotonin in blood; dietetics |
| 01/22/2004 | US20040014689 Endoparaciticidal and ectoparasiticidal agents |
| 01/22/2004 | US20040014686 Combination of catechin and quercetin for pharmaceutical or dietary use |
| 01/22/2004 | US20040014685 Compounds, compositions and methods for treatment of inflammatory diseases and conditions |
| 01/22/2004 | US20040014684 Hepatoprotective activity of 2'-p-hydroxybenzoylmussaenosidic |
| 01/22/2004 | US20040014682 Solvent extraction using alcohol; immunosuppressants; autoimmune diseases; rheumatic diseases |
| 01/22/2004 | US20040014681 Method for treating dermatoses and tissue damage |
| 01/22/2004 | US20040014680 Mixing drug with sugar alcohol and, or (mono- or di-)saccharide; low melting point; compression; heating |
| 01/22/2004 | US20040014679 Headache therapy |
| 01/22/2004 | US20040014677 Antiinflammatory agents; antihistamines; brain disorders; Alzheimer's disease; inflammatory bowel disorders; antiarthritic agents |
| 01/22/2004 | US20040014676 SRC kinase inhibitors useful for treating osteoporosis |
| 01/22/2004 | US20040014675 Anticancer products for treating cystic fibrosis |
| 01/22/2004 | US20040014672 Novel crystalline form of 6-hydroxy-3-(4-[2-(piperidin-1-yl)ethoxy]phenoxy)-2-(4-methoxyphenyl)benzo[b]thiophene hydrochloride |
| 01/22/2004 | US20040014668 Human NK3-related prostate specific gene 1 |
| 01/22/2004 | US20040014662 Modulation of neural stem cells and neural progenitor cells |
| 01/22/2004 | US20040014656 Method for diagnosing neuronal deseases and for treating primary hemostasis deficiency |
| 01/22/2004 | US20040014655 Pharmaceutical compositions containing plasma protein |
| 01/22/2004 | US20040014651 Treating the effects of nicotine |
| 01/22/2004 | US20040014648 Methods for the prevention and/or the treatment of neurological disorders |
| 01/22/2004 | US20040014642 Inositol pyrophosphates, and methods of use thereof |
| 01/22/2004 | US20040014635 Anticancer agents |
| 01/22/2004 | US20040014601 Adjust concentration of plant protein using peracetic acid, salicylic acid; gene encoding transcription factor |
| 01/22/2004 | US20040014590 Modulation pressure; efficient solvent extraction |
| 01/22/2004 | US20040014187 Comprises genetically engineered protease for treatment tumors; gene therapy |
| 01/22/2004 | US20040014147 Utilizing an adenosine kinase as a surrogate analyte; methods of using the compounds in a variety of in vitro, in vitro and ex vivo contexts |
| 01/22/2004 | US20040014057 Targeted chromosomal genomic alterations with modified single stranded oligonucleotides |
| 01/22/2004 | US20040014037 Release factors (RF-1) polypeptides and DNA (RNA) encoding RF-1 polypetides and methods for producing such polypeptides by recombinant techniques; utilizing RF-1 polypeptides to screen for antibiotics |
| 01/22/2004 | US20040013747 An anaesthetic mixture comprising a drug, acids, a metal nitrite; a membrane is used to prevent direct contact of the skin while diffusing the active drug and nitric oxide vasodilator; topical application |
| 01/22/2004 | US20040013741 Gastrointestinal compositions |
| 01/22/2004 | US20040013740 Antitumor agents for treating tumor of mucosa, skin; poisons are selected from scolopenders, snakes, spiders or scorpions |
| 01/22/2004 | US20040013731 Drug-complex microparticles and methods of making/using same |
| 01/22/2004 | US20040013730 Insertion into vagina; prevention, therapy for infections |
| 01/22/2004 | US20040013729 Mydriatic agent in viscoelasticity polymer |
| 01/22/2004 | US20040013728 Controlled drug delivery system using the conjugation of drug to biodegradable polyester |
| 01/22/2004 | US20040013727 Hydrophilic gel foaming matrix; cellulose ethers |
| 01/22/2004 | US20040013726 Granulation, crosslinking, drying to powder |
| 01/22/2004 | US20040013725 Storage stable thyroxine active drug formulations and methods for their production |
| 01/22/2004 | US20040013720 Receptor antagonist-lipid conjugates and delivery vehicles containing same |
| 01/22/2004 | US20040013718 Three-dimensional body; antiinflammatory agents, autoimmune diseases; in situ response; side effect reduction |
| 01/22/2004 | US20040013717 PEG-lipid containing formulations |
| 01/22/2004 | US20040013716 Sustained release of drug antagonist; analgesic reservoir, barrier layer |
| 01/22/2004 | US20040013710 Therapy for urogenital diseases or kidney infections in human and animals |
| 01/22/2004 | US20040013708 Mixture containing emulsifiers, proteins and lipophilic starch; food processing |
| 01/22/2004 | US20040013707 Alertness bar |
| 01/22/2004 | US20040013704 Non-polymeric lipophilic pharmaceutical implant compositions for intraocular use |
| 01/22/2004 | US20040013699 Antiprotozoa agents; swine; veterinary medicine |
| 01/22/2004 | US20040013696 Topical applying |
| 01/22/2004 | US20040013693 Liquid pharmaceutical composition |
| 01/22/2004 | US20040013691 Immunotoxin as a therapeutic agent and uses thereof |
| 01/22/2004 | US20040013660 Synergistic mixtures |
| 01/22/2004 | US20040013652 Incotinence; gastrointestinal refluxing; repairing tissue |
| 01/22/2004 | US20040013644 Interferon beta-like molecules |
| 01/22/2004 | US20040013643 Mixture of immunomoderators and antiinflammatory agents |
| 01/22/2004 | US20040013637 Hydrolytically degradable carbamate derivatives of poly(ethylene glycol) |
| 01/22/2004 | US20040013636 Topical polymeric antimicrobial emulsion |
| 01/22/2004 | US20040013628 Cosmetics or dermatological preparations containing polymers having phosphorylcholine side chain |
| 01/22/2004 | US20040013621 Transdermal delivery of antiemetics |
| 01/22/2004 | US20040013620 Antiparkinson agent, dermal penetration enhancer of a safe skin-tolerant sunscreen ester and a volatile liquid |
| 01/22/2004 | US20040013611 Suspension aerosol formulations |
| 01/22/2004 | US20040013609 Screening method |
| 01/22/2004 | US20040011644 For selectively removing one type of molecule from a medium while leaving other types of molecules in the medium using forces unrelated to hydrophic forces, which nonspecifically apply to all lipophilic molecules |
| 01/22/2004 | US20040011356 Medicament respiratory delivery device and cartridge |
| 01/22/2004 | DE20318151U1 Ramipril enthaltende feste pharmazeutische Zusammensetzungen Ramipril containing solid pharmaceutical compositions |
| 01/22/2004 | DE10327874A1 Injektionsanästesiemittel in Kombination mit Xenon Injektionsanästesiemittel in combination with xenon |
| 01/22/2004 | DE10231336A1 Stents Stents |
| 01/22/2004 | DE10230769A1 Neue Arzneimittelkompositionen auf der Basis neuer Anticholinergika und PDE-IV-Inhibitoren New pharmaceutical compositions based on new anticholinergics and PDE IV inhibitors |
| 01/22/2004 | DE10230752A1 Neue Arzneimittelkompositionen auf der Basis von Magnesiumsalzen und Fibrinolytika New pharmaceutical compositions based on magnesium salts and fibrinolytics |
| 01/22/2004 | DE10230751A1 Neue Arzneimittelkompositionen auf der Basis neuer Anticholinergika und EGFR-Kinase-Hemmern New pharmaceutical compositions based on new anticholinergics and EGFR kinase inhibitors |
| 01/22/2004 | DE10230750A1 Neue Arzneimittelkompositionen auf der Basis neuer Anticholonergika und NK1-Rezeptor-Antagonisten New pharmaceutical compositions based on new Anticholonergika and NK1 receptor antagonists |
| 01/22/2004 | DE10230381A1 Verwendung von Inhibitoren der Alanyl-Aminopeptidasen und diese umfassende pharmazeutischen Zubereitungen Use of inhibitors of alanyl-aminopeptidase, and pharmaceutical preparations comprising them |
| 01/22/2004 | DE10230272A1 AT1-Rezeptorantagonisten zur Prävention von Folgeschlaganfällen AT1-receptor antagonists for the prevention of secondary stroke |
| 01/22/2004 | DE10230027A1 Neue Arzneimittelkombinationen auf der Basis von Natriumkanalblockern und Magnesiumsalzen New drug combinations on the basis of sodium channel blockers and magnesium salts |
| 01/22/2004 | DE10228326A1 Verwendung von Macrolid- und/oder Tetracyclin-Verbindungen und/oder Gyrasehemmer enthaltenden Präparationen zur Prophylaxe und therapeutischen Behandlung von Migräne und Migräne-verwandten Erkrankungen Use of macrolide and / or tetracycline compounds and / or gyrase inhibitor-containing preparations for the prophylaxis and therapeutic treatment of migraine and migraine related disorders |